Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Westin J, Davis RE, Feng L, Hagemeister F, et al. J Clin Oncol 2022 Aug 11:JCO2200597. doi: 10.1200/JCO.22.00597.

Read + Share

Amedeo Smart

Independent Medical Education

Westin J, Davis RE, Feng L, Hagemeister F, et al. Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. J Clin Oncol 2022 Aug 11:JCO2200597. doi: 10.1200/JCO.22.00597.
PMID: 35952327